Sanofi bid first, but Biogen won out in fight to acquire Reata — report 

Chris Viehbacher

Sanofi was the mystery “Party A” that engaged in a bidding war with Biogen for the $7.3 billion buyout of Reata Pharmaceuticals, according to a Bloomberg News report, citing unnamed sources.

The French Big Pharma bid for Reata first,…
Click here to view original post